New enzyme discovery could “put the brakes” on Parkinson’s

News

Author: Roisin McCormackPublished: 14 November 2019

Prep: Cook: Serves:

Professor Dario Alessi University of Dundee

Researchers at the University of Dundee, UK, have discovered an enzyme that could reverse mutations in a gene commonly associated with the development of Parkinson’s.

The enzyme, called PPM1H, has been found to naturally prevent the biological activity of LRKK2 – it is hoped this discovery could slowdown the progression of the disease.

The researchers are now working with the university’s Drug Discovery Unit to develop compounds that could activate the newly discovered enzyme.

Professor Dario Alessi, one of the lead researchers, said: “Parkinson’s is like a runaway train – at present we have no way of putting the brakes on to slow it down, let alone stop it. This new enzyme we have found acts as the brakes in the pathway that causes Parkinson’s in humans.

“This finding opens the door for a new chemical approach to the search for Parkinson’s treatments.”

Lead image credit: University of Dundee

To read more on this topic click here.

Researchers awarded £250,000 by UK Medical Research Council

Last Month

Next Month

Go Back

Share this story

Comments

In my country

Building a Parkinson’s network in China

Assessing the Parkinson’s infrastructure in China

Jessica Mann: writing with Parkinson’s

We talk to the British author about living with Parkinson’s for two decad

Parkinson’s Sidekicks: bridging the intergenerational gap

A US art initiative tackling social isolation in Parkinson’s

Students develop wearable device to track Parkinson’s tremors

A wearable device has been developed to monitor Parkinson’s tremors and their severity through the tracking of body movements. The device – Tremor Tracker – was created by two students, Julie Gaudin and Elizabeth Hummel, at Louisiana Tech University, US, as part of a design class project. The students designed an algorithm using data recorded from volunteer participants at Rock Steady, a boxing programme for people with Parkinson’s. They then applied the algorithm to a GENEActiv, a wrist-worn device that has been scientifically validated for clinical research. Hummel, co-creator of the Tremor Tracker, said: “Through supervised machine learning, the device predicts whether a patient’s tremors are parkinsonian or non-parkinsonian, as well as the severity of these tremors. A quantitative analysis of parkinsonian tremors provides a more detailed disease state.”

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

Parkinson’s could be present from birth, study finds

Parkinson’s may be present from birth in younger people with the condition, new research has found. The study – conducted by Cedars-Sinai Medical Centre, US, and published in ‘Nature Medicine’ journal – used induced stem cells from people with young-onset Parkinson’s, to grow dopamine-producing neurons and observe them for early warning signs of the condition. An abnormal pile-up of protein was found during the neurons’ development, including alpha-synuclein; which occurs in Parkinson’s. The scientists conjecture that Parkinson’s symptoms appear when the pile-up continues over 20 or 30 years. The team also found that the drug PEP005 – currently used against skin precancers – could help treat the condition. Michele Tagliati, vice chair and professor at Cedars-Sinai’s Department of Neurology and the study’s co-author, said: “This exciting new research provides hope that one day we may be able to detect and take early action to prevent this disease in at-risk individuals.”…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

New enzyme discovery could “put the brakes” on Parkinson’s

News

Author: Roisin McCormackPublished: 14 November 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

In my country

Building a Parkinson’s network in China

Interviews

Jessica Mann: writing with Parkinson’s

Interviews

Parkinson’s Sidekicks: bridging the intergenerational gap

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Parkinson’s could be present from birth, study finds

{title}

Subscribe

New enzyme discovery could “put the brakes” on Parkinson’s

News

Author: Roisin McCormackPublished: 14 November 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

In my country

Building a Parkinson’s network in China

Interviews

Jessica Mann: writing with Parkinson’s

Interviews

Parkinson’s Sidekicks: bridging the intergenerational gap

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Parkinson’s could be present from birth, study finds

{title}

Subscribe

Sign in